SMS Lifesciences India Ltd Stock Price Today (NSE: SMSLIFE)
Fundamental Score
SMS Lifesciences India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
SMS Lifesciences India Ltd share price today is ₹1258.80, up +0.00% on NSE/BSE as of 22 June 2026. SMS Lifesciences India Ltd (SMSLIFE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹421.48 (Cr). The 52-week high for SMSLIFE share price is ₹1539.00 and the 52-week low is ₹1067.00. At a P/E ratio of 22.54x, SMSLIFE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 10.76% and a debt-to-equity ratio of 0.34.
SMS Lifesciences India Ltd Share Price Chart — NSE/BSE Historical Performance
SMS Lifesciences India Ltd share price chart: 3.16% return over the past month. 52-week high ₹1539.00, 52-week low ₹1067.00.
SMS Lifesciences India Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1268.00 | ₹1268.00 | ₹1256.00 | ₹1258.80 | 78.00 (Cr) | |
| ₹1247.90 | ₹1340.00 | ₹1247.90 | ₹1268.00 | 130.00 (Cr) | |
| ₹1295.00 | ₹1295.00 | ₹1288.50 | ₹1288.50 | 28.00 (Cr) | |
| ₹1299.00 | ₹1299.00 | ₹1265.10 | ₹1291.60 | 75.00 (Cr) | |
| ₹1299.90 | ₹1299.90 | ₹1250.00 | ₹1299.00 | 50.00 (Cr) | |
| ₹1300.10 | ₹1300.10 | ₹1271.30 | ₹1293.50 | 53.00 (Cr) | |
| ₹1324.00 | ₹1324.00 | ₹1305.00 | ₹1305.00 | 456.00 (Cr) | |
| ₹1336.90 | ₹1340.00 | ₹1315.00 | ₹1324.00 | 758.00 (Cr) | |
| ₹1384.00 | ₹1384.00 | ₹1310.10 | ₹1315.80 | 507.00 (Cr) | |
| ₹1354.00 | ₹1375.00 | ₹1330.00 | ₹1352.90 | 1.11K (Cr) |
SMS Lifesciences India Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1291.10 | ₹1384.00 | ₹1247.90 | ₹1258.80 | -2.50% | |
| ₹1393.50 | ₹1440.50 | ₹1204.80 | ₹1324.00 | -4.99% | |
| ₹1182.00 | ₹1539.00 | ₹1141.20 | ₹1393.50 | +17.89% | |
| ₹1123.20 | ₹1211.10 | ₹1100.60 | ₹1181.80 | +5.22% | |
| ₹1169.00 | ₹1259.90 | ₹1100.00 | ₹1127.70 | -3.53% | |
| ₹1138.60 | ₹1305.40 | ₹1067.00 | ₹1131.30 | -0.64% | |
| ₹1197.30 | ₹1376.60 | ₹1080.00 | ₹1132.70 | -5.40% | |
| ₹1143.60 | ₹1229.90 | ₹1143.30 | ₹1215.80 | +6.31% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Microcap API player riding government tailwinds; execute or evaporate.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search.
CORE STORY (THE REAL GAME)
- Industry tailwinds from government support and focus on domestic manufacturing
- Relatively discounted valuation compared to industry peers
- Positive short-term price momentum
- Significant order wins in API/intermediates
- Positive regulatory developments (e.g., USFDA approvals)
- Successful capacity expansion and backward integration
- Microcap liquidity risk
- Negative free cash flow
- Dependence on government incentives
FII: 0.0% (Δ -0.03%), DII: 0.03% (Δ 0.03%) - Minimal institutional interest
Government focus on promoting domestic pharma manufacturing is a tailwind
No, Free Cash Flow 5Y: ₹-58.51 Cr
If Haleos Labs can capitalize on the government's push for domestic API manufacturing and improve its cash flow, it could see significant upside. However, execution is key, and the microcap nature of the stock adds significant risk.
Primary Thesis Risk
Reliance on government incentives and poor cash flow make this a binary bet.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
SMS Lifesciences India Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
SMS Lifesciences India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SMSLIFE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 22.54 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (30.62%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Balanced Promoter Holding (71.41%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Negative Free Cash Flow (₹-58.51 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
SMS Lifesciences India Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare SMS Lifesciences India Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
SMS Lifesciences India LtdSMS Lifescience...Selected✓ SMSLIFE • 540679 | 46.6/100 | ₹1258.80₹1259 | ₹421.48₹421.48 | 22.54Average 22.5 Average | 10.76%Average 10.76% Average | 11.78%Average 11.78% Average | 0.34Excellent 0.3 Excellent | 14.63%Good 14.63% Good | 5.74%Good 5.74% Good | 0.11% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
SMS Lifesciences India Ltd PE Ratio History
Historical price-to-earnings ratio for SMSLIFE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹66.51 | ₹1324.00 | 19.9x |
| FY 2024 | ₹30.08 | ₹1176.00 | 39.1x |
| FY 2023 | ₹37.92 | ₹529.60 | 14x |
| FY 2022 | ₹83.76 | ₹625.50 | 7.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
SMS Lifesciences India Ltd Dividend History
Annual cash dividends paid by SMSLIFE — dividend yield 0.11%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.45 Cr |
| FY 2024 | ₹0.45 Cr |
| FY 2023 | ₹0.45 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
SMS Lifesciences India Ltd Quarterly Performance
Latest quarterly metrics for SMSLIFE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
3.71%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
30.62%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
5.74%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
14.63%
Compounded annual net profit growth over 5 years
SMS Lifesciences India Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SMSLIFE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
SMS Lifesciences India Ltd Financial Statements
Annual income statement, balance sheet and cash flow for SMS Lifesciences India Ltd (SMSLIFE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for SMS Lifesciences India Ltd
About SMSLIFE (SMS Lifesciences India Ltd)
SMS Lifesciences India Ltd is a dynamic pharmaceutical company deeply rooted in the manufacturing and supply of vital active pharmaceutical ingredients (APIs) and advanced intermed...iates. Dedicated to advancing healthcare solutions, SMSLIFE focuses on developing and producing a wide spectrum of therapeutic solutions. With a commitment to quality and innovation, the company caters to diverse medical needs, ensuring access to affordable and effective medications globally. SMSLIFE operates with state-of-the-art manufacturing facilities, adhering to stringent regulatory standards to consistently deliver pharmaceutical products that meet the highest quality benchmarks. Their dedication extends to research and development, continuously seeking new pathways to enhance existing treatments and pioneer novel APIs that improve patient outcomes. SMSLIFE's therapeutic scope encompasses a broad range of critical healthcare areas, addressing prevalent and emerging medical conditions. This includes APIs for managing cardiovascular ailments, neurological disorders, and oncological treatments, showcasing their versatility. The company also offers solutions for infectious diseases, gastrointestinal issues, and endocrine imbalances, reflecting its commitment to comprehensive healthcare. SMSLIFE emphasizes innovation, constantly exploring advanced drug delivery systems and novel formulations to enhance the efficacy and patient experience. Their commitment to patient well-being is reflected in the meticulous care taken in manufacturing processes, adhering to strict quality control measures at every stage. This unwavering dedication underscores their mission to positively impact lives and contribute to a healthier world. Building on a foundation of trust and reliability, SMS Lifesciences India Ltd prides itself on its commitment to ethical business practices and sustainability. SMSLIFE cultivates strong partnerships with pharmaceutical companies, healthcare providers, and research institutions worldwide, fostering collaborative efforts that drive medical advancements. Their customer-centric approach ensures they are responsive to market needs and evolving healthcare trends. With a dedicated team of experienced scientists, engineers, and industry professionals, SMSLIFE continues to expand its capabilities and product portfolio. Driven by a passion for improving global health, SMSLIFE remains steadfast in its pursuit of excellence, striving to be a leading provider of high-quality APIs and intermediates that empower healthcare systems and enhance patient well-being.
Company Details
Key Leadership
Corporate Events
SMSLIFE Share Price: Frequently Asked Questions
What is the current share price of SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd (SMSLIFE) trades at ₹1258.80 on NSE and BSE. Market cap ₹421.48 (Cr). Educational data only.
What is the P/E ratio of SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd has a P/E of 22.54x vs industry average 31.77x.
What is the Bull Run score for SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd has a Bull Run score of 46.6/100 based on 25+ financial parameters.
Does SMS Lifesciences India Ltd pay dividends?
SMS Lifesciences India Ltd has a dividend yield of 0.11%. Past dividends don't guarantee future payments.
What is the ROE of SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd has ROE of 10.76%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd has debt-to-equity of 0.34.
Is SMS Lifesciences India Ltd a good investment?
Bull Run gives SMS Lifesciences India Ltd a score of 46.6/100. This is not investment advice — consult a SEBI-registered advisor.